European Case Law Identifier: | ECLI:EP:BA:1999:T037996.19990113 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 13 January 1999 | ||||||||
Case number: | T 0379/96 | ||||||||
Application number: | 89312270.5 | ||||||||
IPC class: | A61K 9/12 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | B | ||||||||
Download and more information: |
|
||||||||
Title of application: | Medicinal aerosol formulations | ||||||||
Applicant name: | Riker Laboratories, Inc. | ||||||||
Opponent name: | (01) Norton Healthcare Ltd (02) Schering Corporation (03) Boehringer Ingelheim GmbH (04) Professor Sylvain RAULT (05) SmithKline Beecham plc (06) Fisons plc |
||||||||
Board: | 3.3.02 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Inventive step - no - for all admitted requests - obvious substitution of a compound of a composition Request on the basis of Article 125 EPC or Article 32 TRIPS to refer a question of law to the Enlarged Board of Appeal or to the European Court of Justice - not admitted into the proceedings |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t960379eu1.html
Date retrieved: 17 May 2021